Risk of metastasis and survival in patients undergoing different treatment strategies with T1 colonic neuroendocrine tumors

被引:1
|
作者
Wu, X. [1 ]
Peng, C. [1 ]
Lin, M. [1 ]
Li, Z. [1 ,2 ]
Yang, X. [1 ,2 ,3 ]
Liu, J. [1 ]
Zuo, X. [1 ,2 ,4 ]
机构
[1] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Gastroenterol, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Lab Translat Gastroenterol, Jinan, Shandong, Peoples R China
[3] Shandong Univ, Qilu Hosp, Clin Epidemiol Unit, Jinan, Shandong, Peoples R China
[4] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Robot Engn Lab Precise Diag & Therapy GI Tumor, Jinan, Shandong, Peoples R China
关键词
Colonic neuroendocrine tumors; Metastasis risk; SEER; Survival; Treatment strategies; CARCINOID-TUMORS; RECTAL NEUROENDOCRINE; CONSENSUS GUIDELINES; DIAGNOSIS; EPIDEMIOLOGY; MANAGEMENT; SIZE;
D O I
10.1007/s40618-023-02185-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
\Purpose The efficacy and safety of local excision (LE) for small (< 1-2 cm) colonic neuroendocrine tumors (NETs) is controversial due to the higher metastasis risk when compared with rectal NETs. The study aimed to evaluate the metastasis risk of T1 colonic NETs and compare patients' long-term prognosis after LE or radical surgery (RS). Methods The Surveillance Epidemiology and End Results database was used to identify patients with T1 colonic NETs (2004.2015). Multivariable logistic regression was performed to assess factors associated with metastasis risk. Propensity score matching was used to balance the variables. Cancer-specific survival (CSS) and overall survival (OS) were calculated to estimate the prognosis of patients with T1N0M0 colonic NETs who underwent LE or RS. Results Of the 610 patients with colonic NETs, 46 (7.54%) had metastasis at diagnosis. Tumor size (11-20 mm) (OR = 9.51; 95% confidence interval (CI): 4.32.21.45; P < 0.001), right colon (OR = 15.79; 95% CI 7.20.38.56; P < 0.001), submucosal infiltration (OR = 2.08; 95% CI 0.84.5.57; P = 0.125) were independent risk factors associated with metastasis. Of the 515 patients with T1N0M0 colonic NETs, the overall long-term prognosis of LE was as good as that of RS groups (after matching, 5-year CSS: 97.9% vs. 94.6%, P = 0.450; 5-year OS: 92.7% vs. 85.6%, P = 0.009). Conclusion Tumor size (11.20 mm) and site (right colon) are associated with metastasis in T1 colonic NETs. In the absence of metastasis, LE could be a viable option for 0.10 mm T1 colonic NETs with well/moderate differentiation in the left colon in terms of long-term survival.
引用
收藏
页码:671 / 681
页数:11
相关论文
共 50 条
  • [1] Risk of metastasis and survival in patients undergoing different treatment strategies with T1 colonic neuroendocrine tumors
    X. Wu
    C. Peng
    M. Lin
    Z. Li
    X. Yang
    J. Liu
    X. Yang
    X. Zuo
    Journal of Endocrinological Investigation, 2024, 47 : 671 - 681
  • [2] Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors
    Ngamruengphong, Saowanee
    Kamal, Ayesha
    Akshintala, Venkata
    Hajiyeva, Gulara
    Hanada, Yuri
    Chen, Yen-, I
    Sanaei, Omid
    Fluxa, Daniela
    Chavez, Yamile Haito
    Kumbhari, Vivek
    Singh, Vikesh K.
    Lennon, Anne Marie
    Canto, Marcia Irene
    Khashab, Mouen A.
    GASTROINTESTINAL ENDOSCOPY, 2019, 89 (03) : 602 - 606
  • [3] Risk factors for metastasis and survival of patients with T1 gastric neuroendocrine carcinoma treated with endoscopic therapy versus surgical resection
    Ye, Hua
    Yuan, Yuan
    Chen, Ping
    Zheng, Qi
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2022, 36 (08): : 6162 - 6169
  • [4] Risk factors for metastasis and survival of patients with T1 gastric neuroendocrine carcinoma treated with endoscopic therapy versus surgical resection
    Hua Ye
    Yuan Yuan
    Ping Chen
    Qi Zheng
    Surgical Endoscopy, 2022, 36 (8) : 6162 - 6169
  • [5] Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
    Choi, Jin Sun
    Kim, Min Jung
    Shin, Rumi
    Park, Ji Won
    Heo, Seung Chul
    Jeong, Seung-Yong
    Park, Kyu Joo
    Ryoo, Seung-Bum
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2414 - 2424
  • [6] Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment
    Zhou, Yu-Jie
    Wang, Qi-Wen
    Zhang, Qing-Wei
    Chen, Jin-Nan
    Wang, Xin-Yuan
    Gao, Yun-Jie
    Li, Xiao-Bo
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [7] Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors
    Folkert, Ian W.
    Sinnamon, Andrew J.
    Concors, Seth J.
    Bennett, Bonita J.
    Fraker, Douglas L.
    Mahmoud, Najjia N.
    Metz, David C.
    Stashek, Kristen M.
    Roses, Robert E.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (03) : 855 - 863
  • [8] Influence of Old Age on Risk of Lymph Node Metastasis and Survival in Patients With T1 Colorectal Cancer: A Population-Based Analysis
    Ye, Hua
    Zheng, Bin
    Zheng, Qi
    Chen, Ping
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Risk Factors of Lymph Node Metastasis in Patients with Pancreatic Neuroendocrine Tumors (PNETs)
    Wang, Zhe
    Cao, Feng
    Zhang, Yupeng
    Fang, Yu
    Li, Fei
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [10] Survival benefit of pancreatic enzyme replacement therapy in patients undergoing treatment of pancreatic neuroendocrine tumours
    Thompson, Oscar
    Hall, Lewis
    Roberts, Keith
    Bradley, Elizabeth
    Powell-Brett, Sarah
    Pande, Rupaly
    Shah, Tahir
    HPB, 2022, 24 (11) : 1921 - 1929